Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Blood ; 108(9): 2965-71, 2006 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-16835384

RESUMO

Hematopoietic stem cell gene transfer of the drug-resistance gene cytidine deaminase (CDD) protecting cells from the cytotoxic cytidine analogs cytarabine and gemcitabine was investigated in a murine transplant model. Following transplantation of CDD-transduced cells and cytarabine application (500 mg/kg; days 1-4; intraperitoneally) significant myeloprotection was demonstrated with nadir counts of peripheral blood granulocytes and thrombocytes of 2.9 +/- 0.6/nL versus 0.7 +/- 0.1/nL (P < .001) and 509 +/- 147/nL versus 80 +/- 9/nL (P = .008), respectively (CDD versus control). Protection also was observed from otherwise lethal gemcitabine treatment (250 mg/kg; days 1-3). Stable levels of gene-marked cells in primary and secondary recipients were demonstrated for up to 9 months, and whereas CDD overexpression clearly reduced B- and T-lymphocyte numbers, no major toxicity was observed in the myeloid compartment. Despite the profound myeloprotective properties, however, CDD overexpression did not allow for pharmacologic enrichment of transduced hematopoiesis in our model. Thus, in summary, our data establish CDD as a drug-resistance gene highly suitable for myeloprotective purposes, which, given the lack of selection observed in our hands, might best be used in combination with selectable drug-resistance genes such as MGMT (P140K) or MDR1.


Assuntos
Transplante de Medula Óssea/imunologia , Citarabina/toxicidade , Citidina Desaminase/genética , Desoxicitidina/análogos & derivados , Células 3T3 , Animais , Transplante de Medula Óssea/mortalidade , Ensaio de Unidades Formadoras de Colônias , Citidina Desaminase/metabolismo , Desoxicitidina/toxicidade , Técnicas de Transferência de Genes , Sobrevivência de Enxerto/fisiologia , Contagem de Leucócitos , Camundongos , Modelos Animais , Contagem de Plaquetas , Proteínas Recombinantes de Fusão/metabolismo , Gencitabina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...